One of the distinguishing features of tumor promotion is its potential reversibility. If the promoting agent is removed, the initiated cells may revert to a dormant state and not progress to malignancy. This understanding has led to strategies aimed at targeting the tumor-promoting environment. For instance, anti-inflammatory drugs and hormone inhibitors are being explored as potential treatments to disrupt the tumor-promoting processes.
